This is further corroborated by our clinical correlation analysis, where SASH1 expression levels were significantly correlated with survival status, gender, and clinical stage, indicating that its loss is closely linked to tumor progression and malignancy[32]. The gene discussed is SASH1; the disease is neoplasm.